DLC & DPAC Comment on Medicare CGM Coverage
DLC & DPAC submitted comments to the Centers for Medicare & Medicaid Services regarding the agency’s proposed rule on Medicare CGM coverage. We welcome a shorter, more predictable pathway to Medicare coverage for all U.S. Food and Drug Administration-approved CGM products but have grave concerns regarding proposed reimbursement changes that could disrupt CGM access for more than 100,000 seniors. Read the comments in full here.
The DLC in Action
Learn about our commitment to important topics, including: